These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19728098)

  • 81. Self-reference in psychosis and depression: a language marker of illness.
    Fineberg SK; Leavitt J; Deutsch-Link S; Dealy S; Landry CD; Pirruccio K; Shea S; Trent S; Cecchi G; Corlett PR
    Psychol Med; 2016 Sep; 46(12):2605-15. PubMed ID: 27353541
    [TBL] [Abstract][Full Text] [Related]  

  • 82. From maps to mechanisms through neuroimaging of schizophrenia.
    Meyer-Lindenberg A
    Nature; 2010 Nov; 468(7321):194-202. PubMed ID: 21068827
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Altered amygdala shape trajectories and emotion recognition in youth at familial high risk of schizophrenia who develop psychosis.
    Guimond S; Mothi SS; Makowski C; Chakravarty MM; Keshavan MS
    Transl Psychiatry; 2022 May; 12(1):202. PubMed ID: 35562339
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.
    Keshavan MS; Mehta UM; Padmanabhan JL; Shah JL
    Dev Psychopathol; 2015 May; 27(2):615-35. PubMed ID: 25997775
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.
    Archer T; Ricci S; Garcia D; Ricciardi MR
    Neurotox Res; 2014 Nov; 26(4):400-13. PubMed ID: 24804834
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The many roads to psychosis: recent advances in understanding risk and mechanisms.
    Bearden CE; Forsyth JK
    F1000Res; 2018; 7():. PubMed ID: 30631427
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The lifetime trajectory of schizophrenia and the concept of neurodevelopment.
    Andreasen NC
    Dialogues Clin Neurosci; 2010; 12(3):409-15. PubMed ID: 20954434
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.
    Hirvonen J; Hietala J
    CNS Neurosci Ther; 2011 Apr; 17(2):89-96. PubMed ID: 21199447
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dynamic endophenotypes and longitudinal trajectories: capturing changing aspects of development in early psychosis.
    Shah JL; Chakravarty MM; Joober R; Lepage M
    J Psychiatry Neurosci; 2016 Apr; 41(3):148-51. PubMed ID: 27116900
    [No Abstract]   [Full Text] [Related]  

  • 90. The environment and schizophrenia.
    van Os J; Kenis G; Rutten BP
    Nature; 2010 Nov; 468(7321):203-12. PubMed ID: 21068828
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Neurodevelopmental model of schizophrenia: update 2012.
    Rapoport JL; Giedd JN; Gogtay N
    Mol Psychiatry; 2012 Dec; 17(12):1228-38. PubMed ID: 22488257
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.
    Hanson DR; Gottesman II
    BMC Med Genet; 2005 Feb; 6():7. PubMed ID: 15707482
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Systems Neuroscience of Psychosis (SyNoPsis) Provides a Promising Framework for Advancing the Field.
    Mittal VA
    Neuropsychobiology; 2017; 75(3):119-121. PubMed ID: 29258110
    [No Abstract]   [Full Text] [Related]  

  • 94. Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies.
    Bishop JR; Zhang L; Lizano P
    Harv Rev Psychiatry; 2022 Jan-Feb 01; 30(1):59-70. PubMed ID: 34995036
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Further studies on a male monozygotic triplet with schizophrenia: cytogenetical and neurobiological assessments in the patients and their parents.
    Jönsson EG; Härnryd C; Johannesson T; Wahlström J; Bergenius J; Bergstedt H; Greitz D; Nyman H; Björck E; Blennow E; Sedvall GC
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(5):239-47. PubMed ID: 9444492
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Genesis of Schizophrenia: An Origin Story.
    Birnbaum R; Weinberger DR
    Am J Psychiatry; 2024 Jun; 181(6):482-492. PubMed ID: 38822584
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinically meaningful biomarkers for psychosis: a systematic and quantitative review.
    Prata D; Mechelli A; Kapur S
    Neurosci Biobehav Rev; 2014 Sep; 45():134-41. PubMed ID: 24877683
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Illness Phase as a Key Assessment and Intervention Window for Psychosis.
    Kohler CG; Wolf DH; Abi-Dargham A; Anticevic A; Cho YT; Fonteneau C; Gil R; Girgis RR; Gray DL; Grinband J; Javitch JA; Kantrowitz JT; Krystal JH; Lieberman JA; Murray JD; Ranganathan M; Santamauro N; Van Snellenberg JX; Tamayo Z; ; Gur RC; Gur RE; Calkins ME
    Biol Psychiatry Glob Open Sci; 2023 Jul; 3(3):340-350. PubMed ID: 37519466
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Schizophrenia or Possession? A Rejoinder to Irmak.
    Koenig HG
    J Relig Health; 2024 Feb; 63(1):577-581. PubMed ID: 36806959
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Using longitudinal imaging to map the 'relapse signature' of schizophrenia and other psychoses.
    Cropley VL; Pantelis C
    Epidemiol Psychiatr Sci; 2014 Sep; 23(3):219-25. PubMed ID: 24849668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.